The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
10X GENOMICS INC CL A COM 88025U109 407 3,268 SH   DFND   0 3,268 0
ASANA INC CL A 04342Y104 2,516 87,368 SH   DFND   0 87,368 0
DATADOG INC CL A COM 23804L103 703 6,885 SH   DFND   0 6,885 0
GSX TECHEDU INC SPONSORED ADS 36257Y109 4,189 46,483 SH   DFND   0 46,483 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 25,032 1,573,357 SH   DFND   1,573,357 0 0
NUTANIX INC CL A 67059N108 443 19,995 SH   DFND   0 19,995 0
PAGERDUTY INC COM 69553P100 1,004 37,046 SH   DFND   0 37,046 0
PALANTIR TECHNOLOGIES INC CL A 69608A108 573 60,307 SH   DFND   0 60,307 0
PHATHOM PHARMACEUTICALS INC COM 71722W107 8,461 230,727 SH   DFND   230,727 0 0
PROGYNY INC COM 74340E103 116 3,937 SH   DFND   0 3,937 0
SONOS INC COM 83570H108 12,129 799,003 SH   DFND   799,003 0 0
THE REALREAL INC COM 88339P101 8,692 600,664 SH   DFND   600,664 0 0